Is Vicarious Surgical Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NYSE: RBOT) stock is to Strong Buy RBOT stock.
Out of 1 analyst, 1 (100%) are recommending RBOT as a Strong Buy, 0 (0%) are recommending RBOT as a Buy, 0 (0%) are recommending RBOT as a Hold, 0 (0%) are recommending RBOT as a Sell, and 0 (0%) are recommending RBOT as a Strong Sell.
What is RBOT's forecast return on equity (ROE) for 2023-2026?
(NYSE: RBOT) forecast ROE is N/A, which is considered weak.
What is RBOT's Price Target?
According to 1 Wall Street analyst that have issued a 1 year RBOT price target, the average RBOT price target is $9.00, with the highest RBOT stock price forecast at $9.00 and the lowest RBOT stock price forecast at $9.00.
The Wall Street analyst predicted that Vicarious Surgical's share price could reach $9.00 by May 31, 2024. The average Vicarious Surgical stock price prediction forecasts a potential upside of 1,630.77% from the current RBOT share price of $0.52.
What is RBOT's forecast return on assets (ROA) for 2023-2026?
(NYSE: RBOT) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 0%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.